Chondrosarcoma of the larynx

Area of Science:

• Otolaryngology
• Oncology
• Surgical Pathology

Background:

• Laryngeal chondrosarcoma is an exceptionally rare cartilaginous tumor.
• Hoarseness is the predominant presenting symptom.
• Optimal treatment strategies remain a subject of debate.

Purpose of the Study:

• To present a case series of six patients diagnosed with laryngeal chondrosarcoma.
• To review clinical data, treatment modalities, and patient outcomes from a single tertiary care center.

Main Methods:

• Retrospective review of medical records for patients diagnosed with laryngeal chondrosarcoma between 1959 and 2010.
• Data collection encompassed patient demographics, clinical presentation, surgical interventions, adjuvant therapies, and follow-up outcomes.

Main Results:

• Six male patients with a mean age of 53.3 years were identified.
• Surgical interventions included partial laryngectomy (3), total laryngectomy (1), local excision (1), and partial cricoidectomy (1).
• Four patients required permanent tracheostomy; one received chemotherapy and one radiotherapy. Recurrence occurred in two patients, successfully treated with salvage surgery. Long-term follow-up ranged from 12 to 216 months.

Conclusions:

• Findings support partial or total laryngectomy as the primary treatment for laryngeal chondrosarcoma.
• Emphasizes the necessity of long-term surveillance for tumor recurrence.
• Recommends laryngeal preservation when feasible, even if a permanent tracheostomy is required.